Institutional members access full text with Ovid®

Share this article on:

Androgen use for low sexual desire in midlife women

Davis, Susan R. MBBS, PhD

doi: 10.1097/GME.0b013e31828b2fd5
Clinical Corner: Clinical Article

Clinical Scenario: Andrea, a 53-year-old postmenopausal woman, is concerned about her loss of desire for sexual activity. Her last menstrual period occurred 2 years ago, and she has experienced minimal vasomotor symptoms. She has a loving relationship with her husband, to whom she has been married for 5 years and with whom she has previously enjoyed sexual intimacy, often initiating it. She is disturbed by the fact that not only has she no sexual desire but also that she has become unresponsive to her husband’s sexual advances. The problem predates menopause by 1 to 2 years. She has recently heard that testosterone may be a treatment for this and wants to know what options are available.

From the Women’s Health Research Program, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Funding/support: None.

Financial disclosure/conflicts of interest: In the past 2 years, S.R.D. has received investigator-initiated research grant support from Biosante USA and Bayer Health Center; served as a consultant or advisory board member for Biosante, Warner Chilcott, and Trimel; and served as an investigator for Bayer Health Care and Trimel.

Address correspondence to: Susan R. Davis, MBBS, PhD, Women’s Health Research Program, School of Public Health and Preventive Medicine, Monash University, Level 6, The Alfred Center, 99 Commercial Road, Melbourne, VIC 3004, Australia. E-mail: Susan.Davis@monash.edu

© 2013 by The North American Menopause Society.